Genomic Valley Biotech Ltd vs APOLLO HOSPITALS ENTER. L

A side-by-side comparison of Genomic Valley Biotech Ltd (539206) and APOLLO HOSPITALS ENTER. L (APOLLOHOSP) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, APOLLO HOSPITALS ENTER. L leads 539206 vs APOLLOHOSP on 10 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation13
  • Profitability22
  • Growth02
  • Size & financial health13
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

APOLLOHOSP takes 3/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

282.50
P/E ratio
65.46
2.20
P/B ratio
12.55
0.00%
Dividend yield
0.22%
₹1.18
EPS
₹135.04

Profitability

Even

How efficiently each company turns capital and sales into profit. Higher is better.

0.77%
Return on equity
21.20%
11.84%
Return on capital
17.00%
52.38%
EBITDA margin
15.00%
42.86%
Net margin
7.94%

Growth

APOLLOHOSP takes 2/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

-53.70%
Revenue CAGR (3Y)
14.94%
-64.13%
Profit CAGR (3Y)
33.39%

Size & financial health

APOLLOHOSP takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹9 Cr
Market cap
₹1.29L Cr
₹1 Cr
Revenue
₹25,228 Cr
₹0 Cr
Net profit
₹2,003 Cr
0.00
Debt / equity
0.32
Genomic Valley Biotech Ltd
  • + ["Company is almost debt free."]
  • ["Though the company is reporting repeated profits, it is not paying out dividend", "The company has delivered a poor sales growth of 5.15% over past five years.", "Company has a low return on equity of 3.68% over last 3 years.", "Company has high debtors of 3,136 days.", "Promoter holding has decreased over last 3 years: -21.1%"]
APOLLO HOSPITALS ENTER. L
  • + ["Company has delivered good profit growth of 76.2% CAGR over last 5 years", "Company has been maintaining a healthy dividend payout of 17.7%"]
  • ["Stock is trading at 13.4 times its book value", "Company might be capitalizing the interest cost"]
Genomic Valley Biotech Ltd full analysis APOLLO HOSPITALS ENTER. L full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

539206 vs APOLLOHOSP: Share Price, Valuation & Which to Buy | DocStoX